Cochlear implant

Cochlear implant. A Cochlear Limited device, the Nucleus Cochlear Implant, was the first to be approved by the United States Food and Drug Administration in 1985 for use in US adults, and later in US children. The development of Cochlear implants involved the work of many researchers, including William F. House, Graeme Clark, and Ingeborg Hochmair. The first commercial Cochlear Limited device was released in 1982, and since then, numerous other companies, such as Advanced Bionics and MED-EL, have developed their own versions.

Introduction

The introduction of Cochlear implants has revolutionized the field of Otology, enabling individuals with severe to profound Sensorineural hearing loss to perceive sound. Helen Keller, who was born with the ability to see and hear but lost both senses at a young age, would have potentially benefited from this technology, had it been available during her lifetime. Alexander Graham Bell, the inventor of the Telephone, also worked with Deaf individuals and was a strong advocate for the use of Visible speech and other technologies to aid communication. The development of Cochlear implants has been recognized with numerous awards, including the Lasker-DeBakey Clinical Medical Research Award, which was awarded to Graeme Clark in 2013.

History

The history of Cochlear implants dates back to the 1950s, when André Djourno and Charles Eyriès first experimented with implanting electrodes in the Cochlea. Their work was later built upon by researchers such as William F. House and Graeme Clark, who developed the first commercial devices. The House Ear Institute and the University of Melbourne were instrumental in the development of early Cochlear implants, and researchers such as Ingeborg Hochmair and Blake S. Wilson have made significant contributions to the field. The National Institute on Deafness and Other Communication Disorders has also played a crucial role in funding research and development of Cochlear implants.

Design_and_function

The design and function of Cochlear implants involve the use of an external Sound processor, which captures sound and converts it into electrical signals. These signals are then transmitted to an internal Receiver/stimulator, which is implanted under the skin behind the Ear. The Receiver/stimulator sends the signals to an Electrode array, which is inserted into the Cochlea and stimulates the Auditory nerve. Companies such as Cochlear Limited, Advanced Bionics, and MED-EL have developed different designs and technologies, including the use of Thin-film technology and Nanotechnology. Researchers at institutions such as the Massachusetts Institute of Technology and the University of California, Los Angeles have also explored new materials and designs for Cochlear implants.

Surgical_procedure

The surgical procedure for implanting a Cochlear implant typically involves a Mastoidectomy and the insertion of the Electrode array into the Cochlea. The procedure is usually performed under General anesthesia and requires a high level of skill and expertise, as demonstrated by surgeons such as William F. House and John Niparko. The American Academy of Otolaryngology and the American Neurotology Society have established guidelines and standards for the surgical procedure, and researchers at institutions such as the Johns Hopkins University and the University of Iowa have developed new techniques and technologies to improve outcomes.

Benefits_and_risks

The benefits of Cochlear implants include improved Speech perception and Sound localization, as well as enhanced Quality of life for individuals with severe to profound Sensorineural hearing loss. However, there are also risks associated with the procedure, including Infection, Facial paralysis, and Tinnitus. Researchers such as Graeme Clark and Ingeborg Hochmair have worked to minimize these risks and improve outcomes, and organizations such as the National Institute on Deafness and Other Communication Disorders and the Food and Drug Administration have established guidelines and regulations to ensure the safe and effective use of Cochlear implants. The European Union and the World Health Organization have also recognized the benefits and risks of Cochlear implants and have established policies and guidelines for their use.

Types_of_cochlear_implants

There are several types of Cochlear implants available, including devices from companies such as Cochlear Limited, Advanced Bionics, and MED-EL. These devices differ in terms of their design, functionality, and compatibility with different types of Sound processors and Receiver/stimulators. Researchers at institutions such as the University of California, San Francisco and the University of Oxford have compared the performance and outcomes of different types of Cochlear implants, and organizations such as the American Speech-Language-Hearing Association and the Alexander Graham Bell Association for the Deaf and Hard of Hearing have provided information and resources to help individuals and families make informed decisions about Cochlear implants. The National Institutes of Health and the European Commission have also funded research and development of new types of Cochlear implants, including devices that use Brain-computer interface technology and Nanotechnology. Category:Cochlear implants